NEA Management Company, LLC Q4 2017 Filing
Filed February 8, 2018
Portfolio Value
$2.4T
Holdings
43
Report Date
Q4 2017
Filing Type
13F-HR
All Holdings (43 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —TESARO INC | 10,275,113 | $851.5B | 35.27% | |
| 2 | GLYCEURGLYCOMIMETICS INC | 8,584,128 | $144.1B | 5.97% | |
| 3 | RYTMRHYTHM PHARMACEUTICALS INC | 4,912,306 | $142.8B | 5.91% | |
| 4 | —MERSANA THERAPEUTICS INC | 8,144,267 | $133.8B | 5.54% | |
| 5 | —DERMIRA INC | 3,506,649 | $97.5B | 4.04% | |
| 6 | ARDXARDELYX INC | 14,083,582 | $93.0B | 3.85% | |
| 7 | SENS1GBPSENSEONICS HOLDINGS INC | 30,888,266 | $82.2B | 3.40% | |
| 8 | —EPIZYME INC | 6,460,851 | $81.1B | 3.36% | |
| 9 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 12,025,999 | $80.3B | 3.33% | |
| 10 | CRSPCRISPR THERAPEUTICS AG | 3,220,728 | $75.6B | 3.13% | |
| 11 | —ACHAOGEN INC | 5,215,128 | $56.0B | 2.32% | |
| 12 | —AVEO PHARMACEUTICALS INC | 16,362,694 | $45.7B | 1.89% | |
| 13 | —IMMUNOMEDICS INC | 2,772,643 | $44.8B | 1.86% | |
| 14 | —OBSEVA SA | 4,586,563 | $44.8B | 1.85% | |
| 15 | —CLEMENTIA PHARMACEUTICALS IN | 2,141,697 | $40.6B | 1.68% | |
| 16 | —SYNLOGIC INC | 3,819,410 | $37.0B | 1.53% | |
| 17 | —CASCADIAN THERAPEUTICS INC | 9,064,575 | $33.5B | 1.39% | |
| 18 | —PROTEOSTASIS THERAPEUTICS INC | 5,556,778 | $32.4B | 1.34% | |
| 19 | —STRONGBRIDGE BIOPHARMA PLC | 4,141,308 | $30.0B | 1.24% | |
| 20 | —RA PHARMACEUTICALS INC | 3,493,636 | $29.7B | 1.23% | |
| 21 | —TINTRI INC | 5,253,358 | $26.8B | 1.11% | |
| 22 | —ARSANIS INC | 2,000,000 | $25.5B | 1.06% | |
| 23 | LXRXLEXICON PHARMACEUTICALS INC | 2,382,286 | $23.5B | 0.98% | |
| 24 | AUPHAURINIA PHARMACEUTICALS INC | 4,808,483 | $21.8B | 0.90% | |
| 25 | VRNAVERONA PHARMA PLC | 1,219,674 | $14.5B | 0.60% | |
| 26 | ERYP1EURERYTECH PHARMA SA | 625,000 | $13.8B | 0.57% | |
| 27 | —ENDOLOGIX INC | 2,490,204 | $13.3B | 0.55% | |
| 28 | RIGLUSDRIGEL PHARMACEUTICALS INC | 3,243,150 | $12.6B | 0.52% | |
| 29 | —REGULUS THERAPEUTICS INC | 10,989,910 | $11.4B | 0.47% | |
| 30 | —NIGHTSTAR THERAPEUTICS PLC | 714,285 | $9.4B | 0.39% | |
| 31 | —TRACON PHARMACEUTICALS INC | 2,759,217 | $9.2B | 0.38% | |
| 32 | TREURTRILLIUM THERAPEUTICS INC | 1,250,000 | $9.1B | 0.38% | |
| 33 | —DASAN ZHONE SOLUTIONS INC | 956,255 | $8.9B | 0.37% | |
| 34 | —TREVENA INC | 3,811,691 | $6.1B | 0.25% | |
| 35 | CSBRCHAMPIONS ONCOLOGY INC | 1,562,500 | $6.1B | 0.25% | |
| 36 | —AFFIMED NV | 3,888,888 | $5.1B | 0.21% | |
| 37 | —SUNESIS PHARMACEUTICALS INC | 1,298,274 | $4.8B | 0.20% | |
| 38 | MDBMONGODB INC | 150,000 | $4.5B | 0.18% | |
| 39 | —ARQULE INC | 2,520,316 | $4.2B | 0.17% | |
| 40 | AQAQUANTIA | 239,587 | $2.7B | 0.11% | |
| 41 | —ARCA BIOPHARMA INC | 1,460,209 | $2.0B | 0.08% | |
| 42 | —AKARI THERAPEUTICS PLC | 452,167 | $2.0B | 0.08% | |
| 43 | —OREXIGEN THERAPEUTICS INC | 370,900 | $478.0M | 0.02% |